News

CLINICAL RATIONALE Palmitoylethanolamide (PEA) is an endogenous bioactive lipid with pro-homeostatic and anti-inflammatory properties. Evidence in companion animals indicates that PEA can modulate pathways involved in mast-cell activation, allergic inflammation and neurogenic inflammation suggesting a potential role in canine atopic dermatitis and feline hypersensitivity dermatitis, particularly as part of a broader multimodal approach to inflammatory

**Health Professional Education Event** Event Details: Webinar: The therapeutic scope of medical cannabis in Australian veterinary practice (via Zoom) Date: Tuesday 5th April, 2022 Time: 7.00pm AEST (QLD, NSW, ACT, VIC, TAS), 6.30pm ACST (SA, NT), 5.00pm AWST (WA) Guest Presenters Dr Jaime Olsen Mt Helena Vet and Perth Cat Hospital BVSc MANZCVS (Small Animal